Le Lézard
Classified in: Business
Subjects: LEG, CXP

California Department of Pesticide Regulation Has Proposed To Register SenesTech's ContraPest For Sale And Use in California


FLAGSTAFF, Ariz., May 21, 2018 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, today announced that the California Department of Pesticide Regulation (CDPR) has proposed to register ContraPest® for use in California. This proposed action will be posted for thirty days. With approval, the Company will then be able to market and sell ContraPest throughout California, which is one of the largest state markets for pest control.

SenesTech, Inc. has developed an innovative technology for managing animal pest populations through fertility control as opposed to a lethal approach. The Company's first fertility control product, ContraPest(R), is marketed for use initially in controlling rat infestations. (PRNewsfoto/SenesTech, Inc.)

"California consistently leads the way with respect to innovative and environmentally sensitive policies, and California consumers can be the most demanding of the products they buy and use ? the products must be effective, they must be as safe as possible, they must be ethical, and they must pose the least burden on the planet. These are the qualities that we are committed to and evident in our design of ContraPest. I expect this will be a great market for ContraPest, with rapid adoption, as the California consumers are always ahead of the curve," said Dr. Loretta P. Mayer, co-Founder and CEO of SenesTech.

"We have been preparing for a California launch for some months now, and will aggressively launch our prepared marketing and sales campaigns. We have already booked space at upcoming regional trade shows as well as advertising in the appropriate media, and have provided information to key opinion leaders," said Tom Chesterman, EVP and CFO of SenesTech.

About SenesTech 

SenesTech is changing the paradigm of pest management by targeting the root cause of the problem: reproduction.

ContraPest® is an innovative technology that targets the reproductive capabilities of Norway and roof rats. As a highly palatable liquid, the formulation promotes sustained consumption, helping to reduce fertility in both male and female rats, bringing populations down and keeping them down. Our delivery system is designed to minimize handler exposure, and ContraPest is dispensed inside tamper resistant bait stations, minimizing the risks to non-target species.

As a versatile tool, ContraPest can be used within Integrated Pest Management (IPM) programs to help reduce reproduction and magnify the success of IPM protocols or as a standalone, non-lethal solution for customers that are looking to reduce or eliminate the use of lethal methodologies.

ContraPest is a Restricted Use Pesticide, due to applicator expertise. Please read and comply with all label instructions. For more information visit the SenesTech website at www.senestech.com.

Safe Harbor Statement

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" involve estimates, assumptions, risks and uncertainties and describe future expectations, plans, results, or strategies. Forward looking statements are generally preceded by words such as "may," "future," "believe," "plan," "will" or "should," "continue," "expect," "anticipates," "eventually," "projected" or other comparable terminology. Such forward looking statements include, but are not limited to: our expectations regarding our utilization of operating cash, our expectations regarding operating results, and our expectations related to our product messaging and distribution relationships. You should not unduly rely on forward looking statements because such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors and other risks identified in our filings with the Securities and Exchange Commission. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. We do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.

 

SOURCE SenesTech, Inc.


These press releases may also interest you

at 12:55
Institute for Supply Management® (ISM®) has selected the 2024 recipients of the R. Gene Richter Scholarship, an award presented annually to the top supply management students from across the United States. Recipients were determined based upon a...

at 12:55
BAE Systems (LON: BA) received a $754 million contract award to continue producing the Armored Multi-Purpose Vehicle (AMPV) family of vehicles (FoVs) for the U.S. Army. This contract begins the second phase of full-rate production of AMPVs between...

at 12:50
Scotiabank is pleased to announce it will be recognized on The Globe and Mail's 2024 Report on Business magazine's annual Women Lead Here list for the fourth consecutive year. This annual editorial benchmark identifies top-level Canadian businesses...

at 12:47
"We are profoundly saddened at the passing of our firm's senior counsel Senator Joe Lieberman. We were honored when this great statesman joined our firm when he retired from the Senate over ten years ago. We are grateful for his many contributions to...

at 12:46
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:...

at 12:46
Olympus, a leading global medtech company providing innovative solutions for medical and surgical procedures, announced today a milestone for its iTindtm device with its availability and greater patient access through the largest healthcare group...



News published on and distributed by: